Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1α-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss

Journal of Bone and Mineral Metabolism

Volumn 24, Issue 1, 2006, Pages 11-15

  Mizunuma, Hideki ^a   Shiraki, Masataka ^b   Shintani, Masafumi ^c   Gorai, Itsuo ^d   Makita, Kazuya ^e   Itoga, Shunichi ^f   Mochizuki, Yoshiko ^g   Mogi, Hiromichi ^h   Iwaoki, Yasuhisa ⁱ   Kosha, Shouichirou ^j   Yasui, Toshiyuki ^k   Ishihara, Osamu ^l   Kurabayashi, Takumi ^m   Kasuga, Yoshio ⁿ   Hayashi, Kunihiko ^o  

^a HIROSAKI UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE AND PRACTICE FOR INVOLUTIONAL DISEASES   (Japan)

^c Department of Obstetrics and Gynecology   (Japan)

^d International University of Health and Welfare   (Japan)

^e KEIO UNIVERSITY   (Japan)

^f Tone Central Hospital   (Japan)

^g DOKKYO MEDICAL UNIVERSITY   (Japan)

^h Department of Obstetrics and Gynecology   (Japan)

ⁱ Yoshida General Hospital   (Japan)

^j KAGOSHIMA UNIVERSITY   (Japan)

^k UNIVERSITY OF TOKUSHIMA   (Japan)

^l SAITAMA MEDICAL UNIVERSITY   (Japan)

^m NIIGATA UNIVERSITY   (Japan)

ⁿ ASHIKAGA RED CROSS HOSPITAL   (Japan)

^o GUNMA UNIVERSITY   (Japan)

more..

Author keywords

1 OH vitamin D3; Bone loss; Low dose HRT; Osteoporosis

Indexed keywords

ALFACALCIDOL; CONJUGATED ESTROGEN;

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; OSTEOLYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; BONE DENSITY; DENSITOMETRY, X-RAY; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; HYDROXYCHOLECALCIFEROLS; LUMBAR VERTEBRAE; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES;

EID: 29244470458     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-005-0639-y     Document Type: Article

References (25)

1. WH Utian D Shoupe G Bachmann JV Pinkerton JH Pickar 2001 Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate Fertil Steril 75 1065 1079
2. JH Pickar I Yeh JE Wheeler MF Cunnane L Speroff 2001 Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate Fertil Steril 76 25 31
3. RA Lobo T Bush BR Carr JH Pickar 2001 Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism Fertil Steril 76 13 24
4. M Gambacciani P Monteleone AR Genazzani 2002 Low-dose hormone replacement therapy: effects on bone Climacteric 5 135 139
5. H Mizunuma H Okano M Soda I Kagami S Miyamoto T Tokizawa S Honjo Y Ibuki 1997 Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study Maturitas 27 69 76
6. M Gambacciani M Ciaponi B Cappagli P Monteleone C Benussi G Bevilacqua AR Genazzani 2003 Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy Maturitas 45 175 183
7. R Lindsay JC Gallagher M Kleerekoper JH Pickar 2002 Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women JAMA 287 2668 2676
8. M Gambacciani M Ciaponi B Cappagli AR Genazzani 2001 Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women Am J Obstet Gynecol 185 1180 1185
9. JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick RD Jackson SA Beresford BV Howard KC Johnson JM Kotchen J Ockene Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321 333
10. V Beral Million Women Study Collaborators 2003 Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419 427
11. 3 Calcif Tissue Int 65 16 22
12. JC Gallagher SE Fowler JR Detter SS Sherman 2001 Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss J Clin Endocrinol Metab 86 3618 3628
13. JC Gallagher PB Rapuri G Haynatzki JR Detter 2002 Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers J Clin Endocrinol Metab 87 4914 4923
14. B Ettinger HK Genant CE Cann 1987 Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium Ann Intern Med 106 40 45
15. AH [tmp] MacLennan A [tmp] MacLennan S Wenzel HM Chambers K Eckert 1993 Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial Med J Aust 159 102 106
16. M Shiraki K Kushida M Fukunaga H Kishimoto M Taga T Nakamura K Kaneda H Minaguchi T Inoue H Morii A Tomita K Yamamoto Y Nagata M Nakashima H Orimo 1999 A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis: the Alendronate Phase III Osteoporosis Treatment Research Group Osteoporos Int 10 183 192
17. RR Recker KM Davies RM Dowd RP Heaney 1999 The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: a randomized, controlled trial Ann Intern Med 130 897 904
18. 3 in early postmenopausal women: a population-based 5-year randomized trial J Clin Endocrinol Metab 84 546 552
19. A Cranney G Wells A Willan L Griffith N Zytaruk V Robinson D Black J Adachi B Shea P Tugwell G Guyatt Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group 2002 Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women Endocr Rev 23 508 516
20. DM Black SL Greenspan KE Ensrud L Palermo JA [tmp] McGowan TF Lang P Garnero ML Bouxsein JP Bilezikian CJ Rosen PaTH Study Investigators 2003 The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis N Engl J Med 349 1207 1215
21. P Lips 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications Endocr Rev 22 477 501
22. 3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study Endocr J 43 211 220
23. H Mizunuma H Okano M Soda S Tokizawa I Kagami S Miyamoto S Honjo Y Ibuki 1996 Calcium supplements increase bone mineral density in women with low serum calcium levels during long-term estrogen therapy Endocr J 43 411 415
24. C Li G Samsioe C Borgfeldt PO Bendahl K Wilawan A Aberg 2003 Low-dose hormone therapy and carbohydrate metabolism Fertil Steril 79 550 555
25. A Goudev D Georgiev N Koycheva N Manasiev S Kyurkchiev 2002 Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women Maturitas 43 49 53